|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00333333 |
|
Date of registration:
|
02/06/2006 |
|
Primary sponsor: |
|
|
Public title:
|
Mechanism of Thrombocytopenia in Infants
|
|
Scientific title:
|
Mechanism of Thrombocytopenia in Small for Gestational Age Infants Versus Infants With Maternal Preeclampsia Exposure |
|
Date of first enrolment:
|
June 2006 |
|
Target sample size:
|
30 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00333333 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Cohort, Time Perspective: Prospective
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Kelly Zook, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Christiana Care Health Systems; Thomas Jefferson University Hospital |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Infants who are less than 34 weeks gestation
- Infants born to mothers with preeclampsia
- Infants who are born small for gestational age whose mother did not have preeclampsia
Exclusion Criteria:
- Infants who are greater than 34 weeks gestation
- Infants with known congenital anomalies or known congenital infections
Age minimum:
N/A
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Preeclampsia
|
|
Small for Gestational Age (SGA)
|
|
Thrombocytopenia
|
|
Intervention(s)
|
|
Procedure: Cord blood
|
|
Primary Outcome(s)
|
|
To determine the mechanism of thrombocytopenia in small for gestational age infants versus infants with maternal preeclampsia exposure
[Time Frame: Each infant will only be enrolled during the time of birth until cord blood is collected.]
|
|
Secondary ID(s)
|
|
CCC# 26075
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|